Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LSM6P2 refers to a pseudogene named "LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 2." According to genomic databases, it is not a protein-coding gene but a pseudogene related to the functional LSM6 gene found in yeast (S. cerevisiae)[7][9]. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional due to mutations or lack of regulatory elements required for expression. Thus, LSM6P2 does not produce a functional protein and is not considered a therapeutic target or biologically active molecule. Key clarifications: - LSM6P2 is not an active gene, receptor, or enzyme — it is a pseudogene. - There is no evidence it has any biological, therapeutic, or molecular “target” role[7][9]. - It is not implicated in disease, drug action, biomarker use, or safety concerns. If you require structured information for the functional family (e.g., “LSM6 homologs”), focus on the protein-coding LSM6 or related Sm-like proteins; LSM6P2 itself is not a target and is listed as a pseudogene by key databases[7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 2 (LSM6P2).